Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s12325-020-01570-0
Published Online: 2020-11-27
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicholas, Jacqueline
Zhou, Huanxue
Deshpande, Chinmay
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Text and Data Mining valid from 2020-11-27
Version of Record valid from 2020-11-27
Article History
Received: 18 September 2020
Accepted: 11 November 2020
First Online: 27 November 2020